한빛사논문 | BRIC

김형돈 님의 논문 목록

울산대학교 의과대학, 서울아산병원 종양내과

CV File 368 kb

Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 plus Imatinib for Advanced Treatment-refractory Gastrointestinal Stromal Tumors
- Clin. Cancer Res., Apr 25 2024, | https://doi.org/10.1158/1078-0432.CCR-23-4065
- 2024-04
- 의약학
- 한빛사논문
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
- Nat. Med., Feb 19 2024, | https://doi.org/10.1038/s41591-024-02824-y
- 2024-02
- 의약학
- 한빛사논문
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade
- J. Immunother. Cancer, Online issue publication July 06, 2021, 9:e002428 | doi: 10.1136/jitc-2021-002428
- 2021-07
- 의약학
- 한빛사논문
4‐1BB Delineates Distinct Activation Status of Exhausted Tumor‐Infiltrating CD8+ T cells in Hepatocellular Carcinoma
- Hepatology, published: 28 July 2019 | https://doi.org/10.1002/hep.30881
- 2019-07
- 의약학
- 한빛사논문
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
- Gastroenterology, Available online 24 August 2018 | https://doi.org/10.1053/j.gastro.2018.08.030
- 2018-08
- 의약학
- 한빛사논문, 상위피인용논문
Evaluation of Early-stage Hepatocellular Carcinoma by Magnetic Resonance Imaging with Gadoxetic Acid Detects Additional Lesions and Increases Overall Survival
- Gastroenterology, Available online 27 February 2015 | DOI: http://dx.doi.org/10.1053/j.gastro.2015.02.051
- 2015-02
- 의약학
- 한빛사논문
Optimal Methods for Measuring Eligibility for Liver Transplant in Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization
- J. Hepatol., Available online 18 December 2014 | doi:10.1016/j.jhep.2014.12.013
- 2014-12
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기